BridgeMD
A Study to Evaluate the Long-term Safety and Tolerability of Admilparant in Participants with Pulmonary Fibrosis.
EU CTIS ID: 2025-522373-10-00
What this study is testing
To find out if admilparant is safe and if people with IPF and PPF can take it without having bad side effects over a long period of time.
- Therapeutic confirmatory (Phase III)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Participants must have finished taking study drug and completed the end of treatment visit in either IM027068 or IM0271015 study.
- Participants with IPF must be at least 40 years old and those with PPF must be at least 21 years old when they sign the consent form.
- Women who could get pregnant must use a very effective form of birth control, ideally one that doesn’t rely on the user to work properly. They also need to take a urine or blood pregnancy test on Day 1 to make sure they are not pregnant.
- Men who are having sex with women who can get pregnant must agree to use condoms.
You likely can't join if
- Participant who shows symptoms of heart failure at rest.
- Participant had a lung surgery to remove part of the lung or had a lung transplant in the past.
- Participant has pulmonary arterial hypertension and who was taking one medication but now needs more than one.
The study team makes the final eligibility decision.
Where it's taking place
- Japan
- Korea, Republic of
- Malaysia
- Turkey
- Switzerland
- Colombia
- Canada
- Australia
- India
- Peru
- Chile
- China
- Brazil
- United Kingdom
- Taiwan
- Mexico
- Israel
- Argentina
- United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65+ years, 18-64 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Japan; Korea, Republic of; Malaysia; Turkey; Switzerland; Colombia and 13 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.